{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:52:05Z","timestamp":1791345125021,"version":"4.3.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Spinal Muscular Atrophy (SMA) is a neuromuscular genetic disorder resulting from the mutation or deletion of the\n                    <jats:italic>Survival Motor Neuron 1<\/jats:italic>\n                    (\n                    <jats:italic>SMN1<\/jats:italic>\n                    ) gene and the reduction of the Survival Motor Neuron (SMN) protein. As a result, SMN level in SMA depends on the almost identical copy gene\n                    <jats:italic>SMN2<\/jats:italic>\n                    , which produces a small amount of functional SMN due to a silent mutation in exon 7. SMN deficiency critically impairs spinal cord motoneuron (MN) function, causing progressive degeneration. Advances in SMA therapeutics have significantly improved clinical management and prognosis. However, therapeutic outcomes vary among SMA patients, resulting in broad heterogeneity in phenotypes and clinical trajectories; consequently, more focused investigation on the underlying disease mechanisms is essential. One of the FDA-approved treatments is nusinersen, an antisense oligonucleotide (ASO) designed to enhance\n                    <jats:italic>SMN2<\/jats:italic>\n                    exon 7 splicing and increase SMN protein. The present study used non-SMA and SMA MNs differentiated from human induced Pluripotent Stem Cells (hiPSCs) to analyze the effect of a nusinersen-like ASO treatment on intracellular pathways altered in SMA MNs. ASO treatment efficiently increased SMN, prevented MN degeneration, and decreased apoptotic markers in SMA MNs. Furthermore, treatment increased Gemin3 protein and the NF-\u03baB members, IKK\u03b2 and RelA. Nevertheless, ASO did not revert alterations of the autophagy markers LC3-II and p62\/SQSTM1, and the calpain activation product \u03b1-fodrin 145\/150\u2009kDa. Our observations indicate that nusinersen-like ASO treatment might be insufficient to counteract the full spectrum of intracellular alterations occurring in SMN-reduced MNs. Therefore, supplementary compounds targeting these unrecovered pathways might supply additional protective effects on degenerating MNs.\n                  <\/jats:p>","DOI":"10.1038\/s41419-026-09105-1","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:04:23Z","timestamp":1783947863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antisense oligonucleotides treatment uncovers differences in the modulation of dysregulated intracellular pathways in Spinal Muscular Atrophy motoneurons"],"prefix":"10.1038","volume":"17","author":[{"given":"Maria P.","family":"Miralles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Gimenez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Sansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mart\u00ednez-Espa\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Calder\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1823-0299","authenticated-orcid":false,"given":"Manuel","family":"Portero-Ot\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0528-3102","authenticated-orcid":false,"given":"Rosa M.","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garcera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"9105_CR1","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.tins.2020.11.009","volume":"44","author":"B Wirth","year":"2021","unstructured":"Wirth B. Spinal muscular atrophy: in the challenge lies a solution. Trends Neurosci. 2021;44:306\u201322.","journal-title":"Trends Neurosci"},{"key":"9105_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155\u201365.","journal-title":"Cell"},{"key":"9105_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng0797-265","volume":"16","author":"S Lefebvre","year":"1997","unstructured":"Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet. 1997;16:265\u20139.","journal-title":"Nat Genet"},{"key":"9105_CR4","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA. 1999;96:6307\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9105_CR5","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet. 1999;8:1177\u201383.","journal-title":"Hum Mol Genet"},{"key":"9105_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-genom-102319-103602","volume":"21","author":"B Wirth","year":"2020","unstructured":"Wirth B, Karakaya M, Kye MJ, Mendoza-Ferreira N. Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next. Annu Rev Genom Hum Genet. 2020;21:231\u201361.","journal-title":"Annu Rev Genom Hum Genet"},{"key":"9105_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa075","volume":"2","author":"RI Wadman","year":"2020","unstructured":"Wadman RI, Jansen MD, Stam M, Wijngaarde CA, Curial CAD, Medic J, et al. Intragenic and structural variation in the. Brain Commun. 2020;2:fcaa075.","journal-title":"Brain Commun"},{"key":"9105_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1126\/science.1155085","volume":"320","author":"GE Oprea","year":"2008","unstructured":"Oprea GE, Kr\u00f6ber S, McWhorter ML, Rossoll W, M\u00fcller S, Krawczak M, et al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science. 2008;320:524\u20137.","journal-title":"Science"},{"key":"9105_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ajhg.2017.01.005","volume":"100","author":"M Riessland","year":"2017","unstructured":"Riessland M, Kaczmarek A, Schneider S, Swoboda KJ, L\u00f6hr H, Bradler C, et al. Neurocalcin delta suppression protects against spinal muscular atrophy in humans and across species by restoring impaired endocytosis. Am J Hum Genet. 2017;100:297\u2013315.","journal-title":"Am J Hum Genet"},{"key":"9105_CR10","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1126\/science.1074962","volume":"298","author":"L Pellizzoni","year":"2002","unstructured":"Pellizzoni L, Yong J, Dreyfuss G. Essential role for the SMN complex in the specificity of snRNP assembly. Science. 2002;298:1775\u20139.","journal-title":"Science"},{"key":"9105_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbagrm.2016.12.008","volume":"1860","author":"RN Singh","year":"2017","unstructured":"Singh RN, Howell MD, Ottesen EW, Singh NN. Diverse role of survival motor neuron protein. Biochim Biophys Acta Gene Regul Mech. 2017;1860:299\u2013315.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"9105_CR12","doi-asserted-by":"publisher","first-page":"8622","DOI":"10.1523\/JNEUROSCI.3967-05.2006","volume":"26","author":"H Zhang","year":"2006","unstructured":"Zhang H, Xing L, Rossoll W, Wichterle H, Singer RH, Bassell GJ. Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons. J Neurosci. 2006;26:8622\u201332.","journal-title":"J Neurosci"},{"key":"9105_CR13","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1016\/j.celrep.2017.12.003","volume":"21","author":"CM Simon","year":"2017","unstructured":"Simon CM, Dai Y, Van Alstyne M, Koutsioumpa C, Pagiazitis JG, Chalif JI, et al. Converging mechanisms of p53 activation drive motor neuron degeneration in spinal muscular atrophy. Cell Rep. 2017;21:3767\u201380.","journal-title":"Cell Rep"},{"key":"9105_CR14","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1523\/JNEUROSCI.2396-15.2016","volume":"36","author":"C Fallini","year":"2016","unstructured":"Fallini C, Donlin-Asp PG, Rouanet JP, Bassell GJ, Rossoll W. Deficiency of the survival of motor neuron protein impairs mRNA localization and local translation in the growth cone of motor neurons. J Neurosci. 2016;36:3811\u201320.","journal-title":"J Neurosci"},{"key":"9105_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.mcn.2014.06.006","volume":"61","author":"SK Custer","year":"2014","unstructured":"Custer SK, Androphy EJ. Autophagy dysregulation in cell culture and animals models of spinal muscular atrophy. Mol Cell Neurosci. 2014;61:133\u201340.","journal-title":"Mol Cell Neurosci"},{"key":"9105_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105366","volume":"155","author":"A Sansa","year":"2021","unstructured":"Sansa A, de la Fuente S, Comella JX, Garcera A, Soler RM. Intracellular pathways involved in cell survival are deregulated in mouse and human spinal muscular atrophy motoneurons. Neurobiol Dis. 2021;155:105366.","journal-title":"Neurobiol Dis"},{"key":"9105_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molmed.2012.11.002","volume":"19","author":"G Hamilton","year":"2013","unstructured":"Hamilton G, Gillingwater TH. Spinal muscular atrophy: going beyond the motor neuron. Trends Mol Med. 2013;19:40\u201350.","journal-title":"Trends Mol Med"},{"key":"9105_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2020.01.003","volume":"109","author":"CJJ Yeo","year":"2020","unstructured":"Yeo CJJ, Darras BT. Overturning the paradigm of spinal muscular atrophy as just a motor neuron disease. Pediatr Neurol. 2020;109:12\u201319.","journal-title":"Pediatr Neurol"},{"key":"9105_CR19","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.neuron.2005.12.001","volume":"48","author":"UR Monani","year":"2005","unstructured":"Monani UR. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron. 2005;48:885\u201396.","journal-title":"Neuron"},{"key":"9105_CR20","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.2174\/15665240113139990044","volume":"13","author":"BB Goulet","year":"2013","unstructured":"Goulet BB, Kothary R, Parks RJ. At the \u201cjunction\u201d of spinal muscular atrophy pathogenesis: the role of neuromuscular junction dysfunction in SMA disease progression. Curr Mol Med. 2013;13:1160\u201374.","journal-title":"Curr Mol Med"},{"key":"9105_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S1474-4422(23)00419-2","volume":"23","author":"CJJ Yeo","year":"2024","unstructured":"Yeo CJJ, Tizzano EF, Darras BT. Challenges and opportunities in spinal muscular atrophy therapeutics. Lancet Neurol. 2024;23:205\u201318.","journal-title":"Lancet Neurol"},{"key":"9105_CR22","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ajhg.2008.01.014","volume":"82","author":"Y Hua","year":"2008","unstructured":"Hua Y, Vickers TA, Okunola HL, Bennett CF, Krainer AR. Antisense masking of an hnRNP A1\/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice. Am J Hum Genet. 2008;82:834\u201348.","journal-title":"Am J Hum Genet"},{"key":"9105_CR23","doi-asserted-by":"publisher","first-page":"9618","DOI":"10.1073\/pnas.160181697","volume":"97","author":"Y Hofmann","year":"2000","unstructured":"Hofmann Y, Lorson CL, Stamm S, Androphy EJ, Wirth B. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc Natl Acad Sci USA. 2000;97:9618\u201323.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9105_CR24","doi-asserted-by":"publisher","first-page":"6501","DOI":"10.1021\/acs.jmedchem.8b00741","volume":"61","author":"H Ratni","year":"2018","unstructured":"Ratni H, Ebeling M, Baird J, Bendels S, Bylund J, Chen KS, et al. Discovery of risdiplam, a selective survival of motor neuron-2 (SMN2) gene splicing modifier for the treatment of spinal muscular atrophy (SMA). J Med Chem. 2018;61:6501\u201317.","journal-title":"J Med Chem"},{"key":"9105_CR25","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377:1713\u201322.","journal-title":"N Engl J Med"},{"key":"9105_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02769-4","volume":"18","author":"A \u0141usakowska","year":"2023","unstructured":"\u0141usakowska A, W\u00f3jcik A, Fr\u0105czek A, Aragon-Gawi\u0144ska K, Potulska-Chromik A, Baranowski P, et al. Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: a real-world experience. Orphanet J Rare Dis. 2023;18:230.","journal-title":"Orphanet J Rare Dis"},{"key":"9105_CR27","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s00431-023-04883-8","volume":"182","author":"L Antonaci","year":"2023","unstructured":"Antonaci L, Pera MC, Mercuri E. New therapies for spinal muscular atrophy: where we stand and what is next. Eur J Pediatr. 2023;182:2935\u201342.","journal-title":"Eur J Pediatr"},{"key":"9105_CR28","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1186\/s12887-022-03671-x","volume":"22","author":"JW Day","year":"2022","unstructured":"Day JW, Howell K, Place A, Long K, Rossello J, Kertesz N, et al. Advances and limitations for the treatment of spinal muscular atrophy. BMC Pediatr. 2022;22:632.","journal-title":"BMC Pediatr"},{"key":"9105_CR29","doi-asserted-by":"publisher","first-page":"e39113","DOI":"10.1371\/journal.pone.0039113","volume":"7","author":"D Sareen","year":"2012","unstructured":"Sareen D, Ebert AD, Heins BM, McGivern JV, Ornelas L, Svendsen CN. Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy. PLoS ONE. 2012;7:e39113.","journal-title":"PLoS ONE"},{"key":"9105_CR30","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/brain\/awf155","volume":"125","author":"C Soler-Botija","year":"2002","unstructured":"Soler-Botija C, Ferrer I, Gich I, Baiget M, Tizzano EF. Neuronal death is enhanced and begins during foetal development in type I spinal muscular atrophy spinal cord. Brain. 2002;125:1624\u201334.","journal-title":"Brain"},{"key":"9105_CR31","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1172\/JCI95231","volume":"128","author":"N Rodriguez-Muela","year":"2018","unstructured":"Rodriguez-Muela N, Parkhitko A, Grass T, Gibbs RM, Norabuena EM, Perrimon N, et al. Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes. J Clin Invest. 2018;128:3008\u201323.","journal-title":"J Clin Invest"},{"key":"9105_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s40478-021-01223-5","volume":"9","author":"A Sansa","year":"2021","unstructured":"Sansa A, Hidalgo I, Miralles MP, de la Fuente S, Perez-Garcia MJ, Munell F, et al. Spinal Muscular Atrophy autophagy profile is tissue-dependent: differential regulation between muscle and motoneurons. Acta Neuropathol Commun. 2021;9:122.","journal-title":"Acta Neuropathol Commun"},{"key":"9105_CR33","doi-asserted-by":"publisher","first-page":"12063","DOI":"10.1523\/JNEUROSCI.0608-15.2015","volume":"35","author":"O Biondi","year":"2015","unstructured":"Biondi O, Branchu J, Ben Salah A, Houdebine L, Bertin L, Chali F, et al. IGF-1R reduction triggers neuroprotective signaling pathways in spinal muscular atrophy mice. J Neurosci. 2015;35:12063\u201379.","journal-title":"J Neurosci"},{"key":"9105_CR34","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1007\/s12035-017-0710-4","volume":"55","author":"S Arumugam","year":"2018","unstructured":"Arumugam S, Mincheva-Tasheva S, Periyakaruppiah A, de la Fuente S, Soler RM, Garcera A. Regulation of survival motor neuron protein by the nuclear factor-kappa B pathway in mouse spinal cord motoneurons. Mol Neurobiol. 2018;55:5019\u201330.","journal-title":"Mol Neurobiol"},{"key":"9105_CR35","doi-asserted-by":"publisher","first-page":"e15769","DOI":"10.1371\/journal.pone.0015769","volume":"5","author":"JL Fuentes","year":"2010","unstructured":"Fuentes JL, Strayer MS, Matera AG. Molecular determinants of survival motor neuron (SMN) protein cleavage by the calcium-activated protease, calpain. PLoS One. 2010;5:e15769.","journal-title":"PLoS One"},{"key":"9105_CR36","doi-asserted-by":"crossref","unstructured":"de la Fuente S, Sansa A, Periyakaruppiah A, Garcera A, Soler RM. Calpain inhibition increases smn protein in spinal cord motoneurons and ameliorates the spinal muscular atrophy phenotype in mice. Mol Neurobiol. 2018;56:4414\u201327.","DOI":"10.1007\/s12035-018-1379-z"},{"key":"9105_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2688-5","volume":"11","author":"S de la Fuente","year":"2020","unstructured":"de la Fuente S, Sansa A, Hidalgo I, Vivancos N, Romero-Guevara R, Garcera A, et al. Calpain system is altered in survival motor neuron-reduced cells from in vitro and in vivo spinal muscular atrophy models. Cell Death Dis. 2020;11:487.","journal-title":"Cell Death Dis"},{"key":"9105_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.1054270","volume":"16","author":"MP Miralles","year":"2022","unstructured":"Miralles MP, Sansa A, Beltran M, Soler RM, Garcera A. Survival motor neuron protein and neurite degeneration are regulated by Gemin3 in spinal muscular atrophy motoneurons. Front Cell Neurosci. 2022;16:1054270.","journal-title":"Front Cell Neurosci"},{"key":"9105_CR39","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s00401-023-02607-8","volume":"146","author":"TR Fortuna","year":"2023","unstructured":"Fortuna TR, Kour S, Chimata AV, Mui\u00f1os-B\u00fchl A, Anderson EN, Nelson Iv CH, et al. SMN regulates GEMIN5 expression and acts as a modifier of GEMIN5-mediated neurodegeneration. Acta Neuropathol. 2023;146:477\u201398.","journal-title":"Acta Neuropathol"},{"key":"9105_CR40","doi-asserted-by":"crossref","unstructured":"Clements RT, Fuller LE, Kraemer KR, Radomski SA, Hunter-Chang S, Hall WC, et al. Quantification of Neurite Degeneration with Enhanced Accuracy and Efficiency in an. eNeuro 2022;9:ENEURO.0327-21.2022.","DOI":"10.1523\/ENEURO.0327-21.2022"},{"key":"9105_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07326-w","volume":"16","author":"M Br\u00fcll","year":"2025","unstructured":"Br\u00fcll M, Multrus S, Sch\u00e4fer M, Celardo I, Karreman C, Leist M. Programmed neurite degeneration in human central nervous system neurons driven by changes in NAD. Cell Death Dis. 2025;16:24.","journal-title":"Cell Death Dis"},{"key":"9105_CR42","doi-asserted-by":"crossref","unstructured":"Arumugam S, Garcera A, Soler RM, Tabares L. Smn-deficiency increases the intrinsic excitability of motoneurons. Front Cell Neurosci. 2017;11:269.","DOI":"10.3389\/fncel.2017.00269"},{"key":"9105_CR43","doi-asserted-by":"crossref","unstructured":"Mui\u00f1os-B\u00fchl A, Rombo R, Ling KK, Zilio E, Rigo F, Bennett CF, et al. Long-Term SMN-and Ncald-ASO combinatorial therapy in SMA mice and NCALD-ASO treatment in hiPSC-derived motor neurons show protective effects. Int J Mol Sci. 2023;24:4198.","DOI":"10.3390\/ijms24044198"},{"key":"9105_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1307636","volume":"17","author":"S Rashid","year":"2023","unstructured":"Rashid S, Dimitriadi M. Autophagy in spinal muscular atrophy: from pathogenic mechanisms to therapeutic approaches. Front Cell Neurosci. 2023;17:1307636.","journal-title":"Front Cell Neurosci"},{"key":"9105_CR45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.expneurol.2016.06.032","volume":"283","author":"A Periyakaruppiah","year":"2016","unstructured":"Periyakaruppiah A, de la Fuente S, Arumugam S, Bahi N, Garcera A, Soler RM. Autophagy modulators regulate survival motor neuron protein stability in motoneurons. Exp Neurol. 2016;283:287\u201397.","journal-title":"Exp Neurol"},{"key":"9105_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41420-023-01409-x","volume":"9","author":"A Sansa","year":"2023","unstructured":"Sansa A, Miralles MP, Beltran M, Celma-Nos F, Calder\u00f3 J, Garcera A, et al. ERK MAPK signaling pathway inhibition as a potential target to prevent autophagy alterations in Spinal Muscular Atrophy motoneurons. Cell Death Discov. 2023;9:113.","journal-title":"Cell Death Discov"},{"key":"9105_CR47","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1042\/bj3190683","volume":"319","author":"R Nath","year":"1996","unstructured":"Nath R, Raser KJ, Stafford D, Hajimohammadreza I, Posner A, Allen H, et al. Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem J. 1996;319:683\u201390.","journal-title":"Biochem J"},{"key":"9105_CR48","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1523\/JNEUROSCI.0206-11.2011","volume":"31","author":"S Mincheva","year":"2011","unstructured":"Mincheva S, Garcera A, Gou-Fabregas M, Encinas M, Dolcet X, Soler RM. The canonical nuclear factor-kappa b pathway regulates cell survival in a developmental model of spinal cord motoneurons. J Neurosci. 2011;31:6493\u2013503.","journal-title":"J Neurosci"},{"key":"9105_CR49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm2083","volume":"8","author":"ND Perkins","year":"2007","unstructured":"Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007;8:49\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9105_CR50","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrn2670","volume":"10","author":"AH Burghes","year":"2009","unstructured":"Burghes AH, Beattie CE. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci. 2009;10:597\u2013609.","journal-title":"Nat Rev Neurosci"},{"key":"9105_CR51","doi-asserted-by":"crossref","unstructured":"Signoria I, van der Pol WL, Groen EJN. Innovating spinal muscular atrophy models in the therapeutic era. Dis Model Mech. 2023;16:dmm050352.","DOI":"10.1242\/dmm.050352"},{"key":"9105_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7626","volume":"6","author":"ZW Du","year":"2015","unstructured":"Du ZW, Chen H, Liu H, Lu J, Qian K, Huang CL, et al. Generation and expansion of highly pure motor neuron progenitors from human pluripotent stem cells. Nat Commun. 2015;6:6626.","journal-title":"Nat Commun"},{"key":"9105_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/srep11696","volume":"5","author":"MG Boza-Mor\u00e1n","year":"2015","unstructured":"Boza-Mor\u00e1n MG, Mart\u00ednez-Hern\u00e1ndez R, Bernal S, Wanisch K, Also-Rallo E, Le Heron A, et al. Decay in survival motor neuron and plastin 3 levels during differentiation of iPSC-derived human motor neurons. Sci Rep. 2015;5:11696.","journal-title":"Sci Rep"},{"key":"9105_CR54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2174\/1389202919666180101154916","volume":"19","author":"MA Maretina","year":"2018","unstructured":"Maretina MA, Zheleznyakova GY, Lanko KM, Egorova AA, Baranov VS, Kiselev AV. Molecular factors involved in spinal muscular atrophy pathways as possible disease-modifying candidates. Curr Genom. 2018;19:339\u201355.","journal-title":"Curr Genom"},{"key":"9105_CR55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1042\/BST20180016","volume":"46","author":"F Curmi","year":"2018","unstructured":"Curmi F, Cauchi RJ. The multiple lives of DEAD-box RNA helicase DP103\/DDX20\/Gemin3. Biochem Soc Trans. 2018;46:329\u201341.","journal-title":"Biochem Soc Trans"},{"key":"9105_CR56","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1083\/jcb.147.6.1181","volume":"147","author":"B Charroux","year":"1999","unstructured":"Charroux B, Pellizzoni L, Perkinson RA, Shevchenko A, Mann M, Dreyfuss G. Gemin3: a novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems. J Cell Biol. 1999;147:1181\u201394.","journal-title":"J Cell Biol"},{"key":"9105_CR57","doi-asserted-by":"publisher","first-page":"17372","DOI":"10.1073\/pnas.0508947102","volume":"102","author":"KB Shpargel","year":"2005","unstructured":"Shpargel KB, Matera AG. Gemin proteins are required for efficient assembly of Sm-class ribonucleoproteins. Proc Natl Acad Sci USA. 2005;102:17372\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"9105_CR58","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/hmg\/10.5.497","volume":"10","author":"S Jablonka","year":"2001","unstructured":"Jablonka S, Bandilla M, Wiese S, B\u00fchler D, Wirth B, Sendtner M, et al. Co-regulation of survival of motor neuron (SMN) protein and its interactor SIP1 during development and in spinal muscular atrophy. Hum Mol Genet. 2001;10:497\u2013505.","journal-title":"Hum Mol Genet"},{"key":"9105_CR59","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1128\/MCB.01262-08","volume":"29","author":"BG Burnett","year":"2009","unstructured":"Burnett BG, Mu\u00f1oz E, Tandon A, Kwon DY, Sumner CJ, Fischbeck KH. Regulation of SMN protein stability. Mol Cell Biol. 2009;29:1107\u201315.","journal-title":"Mol Cell Biol"},{"key":"9105_CR60","doi-asserted-by":"crossref","unstructured":"Bizen N, Bepari AK, Zhou L, Abe M, Sakimura K, Ono K, et al. Ddx20, an Olig2 binding factor, governs the survival of neural and oligodendrocyte progenitor cells via proper Mdm2 splicing and p53 suppression. Cell Death Differ. 2022;29:1028\u201341.","DOI":"10.1038\/s41418-021-00915-8"},{"key":"9105_CR61","doi-asserted-by":"publisher","first-page":"8246","DOI":"10.1523\/JNEUROSCI.1941-08.2008","volume":"28","author":"H Gutierrez","year":"2008","unstructured":"Gutierrez H, O\u2019Keeffe GW, Gavalda N, Gallagher D, Davies AM. Nuclear factor kappa B signaling either stimulates or inhibits neurite growth depending on the phosphorylation status of p65\/RelA. J Neurosci. 2008;28:8246\u201356.","journal-title":"J Neurosci"},{"key":"9105_CR62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<151::AID-SYN8>3.0.CO;2-P","volume":"35","author":"BC Albensi","year":"2000","unstructured":"Albensi BC, Mattson MP. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse. 2000;35:151\u20139.","journal-title":"Synapse"},{"key":"9105_CR63","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1046\/j.1471-4159.2000.740647.x","volume":"74","author":"M Nakai","year":"2000","unstructured":"Nakai M, Qin ZH, Chen JF, Wang Y, Chase TN. Kainic acid-induced apoptosis in rat striatum is associated with nuclear factor-kappaB activation. J Neurochem. 2000;74:647\u201358.","journal-title":"J Neurochem"},{"key":"9105_CR64","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ceb.2009.12.002","volume":"22","author":"K Moreau","year":"2010","unstructured":"Moreau K, Luo S, Rubinsztein DC. Cytoprotective roles for autophagy. Curr Opin Cell Biol. 2010;22:206\u201311.","journal-title":"Curr Opin Cell Biol"},{"key":"9105_CR65","doi-asserted-by":"publisher","first-page":"e39405","DOI":"10.1097\/MD.0000000000039405","volume":"103","author":"M Hou","year":"2024","unstructured":"Hou M, Zhang Z, Fan Z, Huang L, Wang L. The mechanisms of Ca2+ regulating autophagy and its research progress in neurodegenerative diseases: a review. Med (Baltim). 2024;103:e39405.","journal-title":"Med (Baltim)"},{"key":"9105_CR66","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1093\/hmg\/ddn234","volume":"17","author":"MP Walker","year":"2008","unstructured":"Walker MP, Rajendra TK, Saieva L, Fuentes JL, Pellizzoni L, Matera AG. SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain. Hum Mol Genet. 2008;17:3399\u2013410.","journal-title":"Hum Mol Genet"},{"key":"9105_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47203-7","volume":"9","author":"D Moakley","year":"2019","unstructured":"Moakley D, Koh J, Pereira JD, DuBreuil DM, Devlin AC, Berezovski E, et al. Pharmacological profiling of purified human stem cell-derived and primary mouse motor neurons. Sci Rep. 2019;9:10835.","journal-title":"Sci Rep"},{"key":"9105_CR68","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1111\/j.1471-4159.2009.06278.x","volume":"110","author":"M Gou-Fabregas","year":"2009","unstructured":"Gou-Fabregas M, Garcera A, Mincheva S, Perez-Garcia MJ, Comella JX, Soler RM. Specific vulnerability of mouse spinal cord motoneurons to membrane depolarization. J Neurochem. 2009;110:1842\u201354.","journal-title":"J Neurochem"},{"key":"9105_CR69","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.nbd.2011.02.003","volume":"42","author":"A Garcera","year":"2011","unstructured":"Garcera A, Mincheva S, Gou-Fabregas M, Caraballo-Miralles V, Llado J, Comella JX, et al. A new model to study spinal muscular atrophy: Neurite degeneration and cell death is counteracted by BCL-X-L Overexpression in motoneurons. Neurobiol Dis. 2011;42:415\u201326.","journal-title":"Neurobiol Dis"},{"key":"9105_CR70","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.0.CO;2-6","volume":"55","author":"V Arce","year":"1999","unstructured":"Arce V, Garces A, de Bovis B, Filippi P, Henderson C, Pettmann B, et al. Cardiotrophin-1 requires LIFRbeta to promote survival of mouse motoneurons purified by a novel technique. J Neurosci Res. 1999;55:119\u201326.","journal-title":"J Neurosci Res"},{"key":"9105_CR71","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382.","journal-title":"Nat Methods"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09105-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09105-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09105-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:40:43Z","timestamp":1791344443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-09105-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9105"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-09105-1","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"869"}}